Biotechnology

Filter

Current filters:

None

Popular Filters

1 to 25 of 2337 results

Biosimilars set to revolutionize global drug development industry

30-09-2014

Intellectual Property and Science business of Thomson Reuters today announced the release of Biosimilars:…

BiosimilarsBiotechnologyGlobalMarkets & MarketingResearch

Karolinska Development appoints Klaus Wilgenbus as interim chief executive

Karolinska Development appoints Klaus Wilgenbus as interim chief executive

30-09-2014

Swedish drug developer Karolinska Development has appointed current board member Klaus Wilgenbus as chief…

BiotechnologyBoardroomKarolinska DevelopmentKlaus WilgenbusSweden

Daiichi Sankyo to buy Ambit Biosciences for up to $410 million

Daiichi Sankyo to buy Ambit Biosciences for up to $410 million

29-09-2014

Daiichi Sankyo and Ambit Biosciences have entered into a definitive merger agreement under which Daiichi…

Ambit BiosciencesBiotechnologyDaiichi SankyoJapanMergers & AcquisitionsOncologyquizartinib

Servier and Pharmacyclics end collaboration on abexinostat pan-HDAC inhibitor compounds

Servier and Pharmacyclics end collaboration on abexinostat pan-HDAC inhibitor compounds

26-09-2014

French privately-held drugmaker Servier is to end its collaboration with Pharmacyclics in the development…

abexinostatBiotechnologyFranceOncologyPharmacyclicsResearchServier

Celgene gains Swissmedic approval of Abraxane for both metastatic pancreatic and breast cancers

Celgene gains Swissmedic approval of Abraxane for both metastatic pancreatic and breast cancers

25-09-2014

Switzerland-based Celgene International, a wholly-owned subsidiary of US biotech major Celgene, say that…

AbraxaneBiotechnologyCelgene Corp.OncologyRegulationSwitzerland

Genzyme collaborates on gene therapy for rare disease that causes childhood blindness

Genzyme collaborates on gene therapy for rare disease that causes childhood blindness

25-09-2014

French pharma major Sanofi subsidiary Genzyme has entered into a research collaboration with the USA’s…

BiotechnologyFranceGenzymeOphthalmicsRare diseasesSanofi

Adaptimmune completes $104 million round of financing to advance cancer therapies

Adaptimmune completes $104 million round of financing to advance cancer therapies

25-09-2014

Adaptimmune, a UK biotech company focused on using T-cell therapy to treat cancer and infectious disease,…

AdaptimmuneBiotechnologyFinancialGlaxoSmithKlineOncologyUK

Baxter and Merrimack enter exclusive licensing agreement for MM-398 compound outside the USA

Baxter and Merrimack enter exclusive licensing agreement for MM-398 compound outside the USA

24-09-2014

Baxter International and oncology specialist Merrimack have launched a collaboration to develop and commercialize…

Baxter InternationalBiotechnologyLicensingMerrimackMM-398OncologyUSA

Acorda Therapeutics to acquire Civitas for $525 million

24-09-2014

US biotech firm Acorda Therapeutics has entered into an agreement to acquire Civitas Therapeutics, a…

Acorda TherapeuticsBiotechnologyCivitas TherapeuticsCVT-301Mergers & AcquisitionsNeurological

Gilead files for Japanese approval of ledipasvir/sofosbuvir for hepatitis C

24-09-2014

Gilead Sciences has submitted a New Drug Application to Japan’s Pharmaceutical and Medical Devices…

Anti-viralsBiotechnologyGilead SciencesJapanledipasvirRegulationsofosbuvir

Gilead's TAF-based HIV regimen meets 48-week primary objective

Gilead's TAF-based HIV regimen meets 48-week primary objective

24-09-2014

Gilead Sciences says that two Phase III clinical trials (Studies 104 and 111) evaluating an investigational…

Anti-viralsBiotechnologyGilead SciencesResearchtenofovir alafenamideUSA

UK’s NICE recommends Celgene’s Revlimid for myelodysplastic syndromes

UK’s NICE recommends Celgene’s Revlimid for myelodysplastic syndromes

24-09-2014

The UK’s drug watchdog the National Institute for Health and Care Excellence (NICE) has today issued…

BiotechnologyCelgene Corp.OncologyPricingRegulationRevlimidUK

FDA fast track designation for AstraZeneca’s MEDI3902

FDA fast track designation for AstraZeneca’s MEDI3902

24-09-2014

Anglo-Swedish pharma major AstraZeneca’s global biologics R&D arm, MedImmune has received fast track…

Antibiotics and Infectious diseasesAstraZenecaBiotechnologyMEDI3902MedImmuneRegulationUSA

Celgene’s psoriasis drug Otezla gains FDA approval

Celgene’s psoriasis drug Otezla gains FDA approval

24-09-2014

The US Food and Drug Administration has approved biotech major Celgene’s Otezla (apremilast), an oral,…

BiotechnologyCelgene Corp.DermatologicalsOtezlaRegulationUSA

Servier and CTI Biopharma collaborate on Pixuvri

23-09-2014

Leading French independent drugmaker Servier and US biotech firm CTI BioPharma have entered into an exclusive…

BiotechnologyCTI BioPharmaLicensingOncologyPixuvriServier

Accinov Innovation Centre gets go ahead for French pharma site

Accinov Innovation Centre gets go ahead for French pharma site

23-09-2014

The French health authority (ANSM) has authorized the Accinov Innovation Centre to open a pharmaceutical…

BiotechnologyFrancePharmaceutical industryPharmacologyResearch

Soligenix appoints Rasappa Arumugham as vice president of biopharma development

Soligenix appoints Rasappa Arumugham as vice president of biopharma development

23-09-2014

Inflammation, oncology and biodefense biopharma company Soligenix has announced the appointment of Rasappa…

BiotechnologyBoardroomRasappa ArumughamSoligenixUSA

Amgen files BLA for BiTE immunotherapy blinatumomab

Amgen files BLA for BiTE immunotherapy blinatumomab

22-09-2014

USA-based Amgen has submitted a Biologics License Application (BLA) to the US Food and Drug Administration…

AmgenBiotechnologyblinatumomabOncologyRegulationUSA

FDA lifts clinical hold on Halozyme's PEGPH20 pancreatic cancer trial

FDA lifts clinical hold on Halozyme's PEGPH20 pancreatic cancer trial

22-09-2014

US biotech firm Halozyme Therapeutics says the US Food and Drug Administration has removed the clinical…

BiotechnologyHalozyme TherapeuticsOncologyPEGH20RegulationResearchUSA

Nanobiotix expands into USA with office in Boston life sciences cluster

Nanobiotix expands into USA with office in Boston life sciences cluster

22-09-2014

France-based Nanobiotix, a clinical-stage nanomedicine company pioneering novel approaches for the local…

BiotechnologyFinancialFranceNanobiotixOncologySanofiUSA

Boehringer Ingelheim and CureVac link on lung cancer immunotherapy

Boehringer Ingelheim and CureVac link on lung cancer immunotherapy

21-09-2014

Family-owned German drug major Boehringer Ingelheim and German clinical-stage biotech company CureVac…

BiotechnologyBoehringer IngelheimCureVacCV9202GlobalLicensingOncology

Biotie receives final European milestone from Lundbeck on Selincro French launch

Biotie receives final European milestone from Lundbeck on Selincro French launch

19-09-2014

Danish CNS drug specialist Lundbeck has brought Selincro (nalmefene) on the market in France. Selincro,…

BiotechnologyBiotie TherapiesFinlandFranceLicensingLundbeckNeurologicalSelincro

1 to 25 of 2337 results

Back to top